Danish-based insulin and enzymesproducer Novo Industri A/S (NVO.CO) said pre-tax earnings fellalmost 10 pct in 1986 though sales rose by two pct.    The pre-tax figure fell to 788 mln crowns from 872 mln in1985, on sales increased from 4.1 billion to 4.2 billion,giving net earnings of 521 mln crowns against 604 mln in 1985.    Earnings per 20-crown share went from 23.79 crowns to 20.45crowns but the company proposed an unchanged 20 pct dividend.    "Foreign exchange fluctuations in 1986 were a verysignificant factor behind developments in the result before andafter tax," Novo said in a statement.    "Not only the U.S. Dollar but also other currenciesessential to Novo fell in 1986 in relation to the Danish crown,"the statement added.    In November 1986, Novo purchased 75 pct of shares in A/SFerrosan, which heads a group specialising in research anddevelopment of CNS (central nervous treatment) treatments andthe sale of pharmaceuticals and vitamins in Scandinavia.    The 357 mln crowns paid in goodwill "had a very limitedeffect on the 1986 result," the Novo statement said. Reuter&#3;